论文部分内容阅读
患者男性,36岁。因间断乏力、纳差5年,再发半月而于1998年11月2日入院。此前曾2次住院行保肝降酶治疗。入院体检:神清,听力正常,皮肤、巩膜无黄染,有肝掌,无蜘蛛痣,心肺叩听无异常发现,腹平软,无压痛,肝脾肋下未触及,双下肢无浮肿。实验室检查:TBil、ALT、AST、Alb、PT/PA均正常,HBsAg(+)、HBsAb(-)、HBeAg(+)、HBeAb(-),HBcAb(+)、抗HBc-IgM(+),HBV-DNA(+)。B超:肝脏质地不均,胆脾无异常。临床诊断为病毒性肝炎,乙型、慢性(轻度)。遂选用干扰素(IFN-αlb,深圳科兴生物制品有限公司生产,商品名:赛若金)抗病毒治疗,剂量为6×10~6U,皮下注射,隔日1次,3个月为1个疗程;另以甘利欣、齐墩果酸保肝。
Male patient, 36 years old. Due to intermittent fatigue, anorexia for 5 years, and then send a half month and on November 2, 1998 admission. Had two hospitalizations before liver enzyme treatment. Admission examination: God clear, normal hearing, skin, sclera no yellow dye, a liver palms, no spider nevus, no abnormalities found in heart and lung beating, abdominal soft, no tenderness, liver and spleen ribs untouched, no swelling of both lower extremities. Laboratory tests showed that HBsAg (+), HBsAb (-), HBeAg (+), HBeAb (-), HBcAb (+) and anti-HBc- IgM (+) were all normal in TBil, ALT, AST, , HBV-DNA (+). B super: uneven liver texture, gallbladder and spleen without exception. Clinical diagnosis of viral hepatitis, B, chronic (mild). Then the choice of interferon (IFN-αlb, Shenzhen Branch Hing Biological Products Co., Ltd., trade name: Sailuo gold) antiviral treatment, the dose of 6 × 10 ~ 6U, subcutaneous injection, every other day, Treatment; the other to Gan Lixin, oleanolic acid liver.